Day

November 1, 2016
The study titled “Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone” was presented on Saturday October 29th. The primary end-point for the study was non-inferior antimicrobial coverage when compared to the same dose given by intravenous infusion. Antimicrobial coverage refers to time over the Minimum Inhibitory Concentration (MIC), a generally accepted measure of the adequacy of...
Complete bioavailability after subcutaneous administration of ceftriaxone — Equivalent antimicrobial coverage (time over MIC) to standard intravenous administration FOR IMMEDIATE RELEASE: Lexington, MA., October 31, 2016 /PRNewswire/ — scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today the presentation of study results at IDWeek 2016 in New Orleans, Louisiana. The...
Once again this year, Lundbeckfonden is awarding talent prizes to four talented young scientists under the age of 30. All four have made remarkable and promising contributions to research at a very early stage of their careers. “Supporting and contributing to the development of the careers of scientists is one of Lundbeckfonden’s cornerstones. These young...

News

How it can help to give an electric shock  
17. July 2018
1,000 old skeletons to provide new knowledge about brain disorders
17. June 2018
Lundbeck Foundation’s magazine out now
1. June 2018

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge